A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV
Clinical trial NCT06557785 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06557785
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2027-03-09
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.